Turel Ozden, Bakir Mustafa, Gonen Ismail, Hatipoglu Nevin, Aydogmus Cigdem, Hosaf Emine, Siraneci Rengin
Department of Pediatrics, Bezmialem Vakif University Faculty of Medicine, Istanbul, Turkey.
Department of Pediatrics, Marmara University Faculty of Medicine, Istanbul, Turkey.
Value Health Reg Issues. 2013 Sep-Oct;2(2):226-230. doi: 10.1016/j.vhri.2013.05.003. Epub 2013 Jul 23.
To evaluate the direct medical cost of hospital admissions for patients with varicella (i.e., chickenpox) to assess the cost burden of varicella from a health care perspective for ultimate use in health economics studies in Turkey.
Records of children hospitalized with varicella at the Bakirkoy Maternity and Children's Hospital between November of 2006 and June of 2011 were reviewed. Reasons for hospitalization, types of varicella-associated complications, and direct medical cost of hospitalization were noted. Patients with underlying risk factors were excluded. Data obtained from one hospital were used to estimate the national cost of the disease.
During the 4.5-year study period, 234 patients were hospitalized with varicella. Of these cases, 48 (20%) children previously ill with underlying cancers or chronic diseases were excluded from the study. Ultimately, 186 previously healthy children (age range: 14 days to 159 months, median age: 14 months) were included. The main reasons for hospitalization were complications related to varicella (79%), the most frequent of which was skin and soft tissue infections, followed by neurological complications and pneumonia. The median cost of hospitalization per patient was US $283, 50% of which was attributed to medication costs. The annual cost for varicella hospitalizations in Turkey was estimated at US $396,200.
A significant number of healthy children are hospitalized for varicella and associated complications. Descriptions of these complications and their related costs provide important data for cost-effectiveness studies for decisions about the inclusion of the varicella vaccine in a childhood vaccination program.
评估水痘(即鸡痘)患者住院的直接医疗费用,从卫生保健角度评估水痘的成本负担,以供土耳其卫生经济学研究最终使用。
回顾了2006年11月至2011年6月期间在巴基尔柯伊妇产儿童医院因水痘住院的儿童记录。记录了住院原因、水痘相关并发症类型以及住院的直接医疗费用。排除有潜在风险因素的患者。从一家医院获得的数据用于估计该疾病的全国成本。
在4.5年的研究期间,有234名患者因水痘住院。在这些病例中,48名(20%)先前患有潜在癌症或慢性病的儿童被排除在研究之外。最终,纳入了186名先前健康的儿童(年龄范围:14天至159个月,中位年龄:14个月)。住院的主要原因是与水痘相关的并发症(79%),其中最常见的是皮肤和软组织感染,其次是神经系统并发症和肺炎。每位患者的住院中位费用为283美元,其中50%归因于药物费用。土耳其水痘住院的年度费用估计为396,200美元。
大量健康儿童因水痘及相关并发症住院。这些并发症及其相关费用的描述为关于将水痘疫苗纳入儿童疫苗接种计划的决策的成本效益研究提供了重要数据。